Home » Newsletters » BioWorld

BioWorld

Oct. 8, 1997

View Archived Issues

Other News To Note

Researchers Take Molecular-Level Look At Blood Clotting

FDA Approves Amgen's Infergen For Hepatitis C

Appointments And Advancements

Lynx Raises Nearly $27M To Support Gene Sequencing

BioTransplant Expands Deal With Novartis For Up To $36M

COR, With Stock Surging, Generates $55M In Offering

House Passes FDA Reform, User Fee Bill Unanimously

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026